TiNT Statistical Analysis Plan v2.0

<p>  </p> <p><strong>TiNT: Trametinib in Neurofibromatosis type 1 associated tumours</strong></p> <p>A phase II study of trametinib in paediatric, adolescent and young adult patients with neurofibromatosis type 1 associated plexiform neurofibromas or progressive optic pathway gliomas</p> <p><strong>Statistical Analysis Plan </strong></p>